257 related articles for article (PubMed ID: 1409032)
1. [Transient diabetes mellitus with ketoacidosis in a child during the treatment of acute lymphoblastic leukemia with L-asparaginase].
Skomra S; Przybylska T
Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):31-2. PubMed ID: 1409032
[TBL] [Abstract][Full Text] [Related]
2. Diabetic ketoacidosis with L-asparaginase therapy.
Mondal R; Nandi M; Tiwari A; Chakravorti S
Indian Pediatr; 2011 Sep; 48(9):735-6. PubMed ID: 21992909
[TBL] [Abstract][Full Text] [Related]
3. [Acido-ketotic acute diabetes in a child treated by L-asparaginase].
Aussannaire M; Cabanes J; Chaussain JL; Maria J
Arch Fr Pediatr; 1972 May; 29(5):527-32. PubMed ID: 4632230
[No Abstract] [Full Text] [Related]
4. Diabetic ketoacidosis secondary to L-asparaginase in acute lymphoblastic leukaemia.
Gifford G; Milliken S; Greenfield J
Intern Med J; 2013 Aug; 43(8):946-8. PubMed ID: 23919338
[TBL] [Abstract][Full Text] [Related]
5. Diabetic ketoacidosis during therapy for pediatric acute lymphoblastic leukemia.
Roberson JR; Raju S; Shelso J; Pui CH; Howard SC
Pediatr Blood Cancer; 2008 Jun; 50(6):1207-12. PubMed ID: 18266226
[TBL] [Abstract][Full Text] [Related]
6. Transient hyperthyroidism following L-asparaginase therapy for acute lymphoblastic leukemia.
Fadilah SA; Faridah I; Cheong SK
Med J Malaysia; 2000 Dec; 55(4):513-5. PubMed ID: 11221167
[TBL] [Abstract][Full Text] [Related]
7. [Diabetic ketoacidosis and hypofibrinogenemia as a complication of the treatment with L-asparaginase of acute lymphoblastic leukemia].
López Herce Cid J; Martínez A; González M; García S
Sangre (Barc); 1986; 31(2):195-9. PubMed ID: 3088740
[No Abstract] [Full Text] [Related]
8. Concurrent diabetic ketoacidosis and pancreatitis in Paediatric acute lymphoblastic leukemia receiving L-asparaginase.
Jameel PZ; Lohiya S; Dongre A; Damke S; Lakhkar BB
BMC Pediatr; 2020 May; 20(1):228. PubMed ID: 32423425
[TBL] [Abstract][Full Text] [Related]
9. [Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase].
Wlazłowski M; Celińska W; Maciejka-Kapuścińska L; Płoszyńska A; Idczak E
Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):296-7. PubMed ID: 7808958
[TBL] [Abstract][Full Text] [Related]
10. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
Hourani R; Abboud M; Hourani M; Khalifeh H; Muwakkit S
Neuropediatrics; 2008 Feb; 39(1):46-50. PubMed ID: 18504683
[TBL] [Abstract][Full Text] [Related]
11. Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia.
Wu SF; Chen AC; Peng CT; Wu KH
Pediatr Blood Cancer; 2008 Dec; 51(6):824-5. PubMed ID: 18726919
[TBL] [Abstract][Full Text] [Related]
12. [Lipidemic alterations in a child with acute lymphoblastic leukemia in treatment with L-aspariginase].
Barisone E; Savino F; Saitta M; Vivenza C; Oderda S; Miniero R; Madon E
Minerva Pediatr; 1994 Apr; 46(4):161-4. PubMed ID: 8084324
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic panniculitis caused by L-asparaginase induced acute pancreatitis in a child with acute lymphoblastic leukemia.
Chiewchengchol D; Wananukul S; Noppakun N
Pediatr Dermatol; 2009; 26(1):47-9. PubMed ID: 19250405
[TBL] [Abstract][Full Text] [Related]
14. [Hyperglycemia as a side effect of using L-asparaginase in children with acute lymphoblastic leukemia (ALL].
Brodkiewicz A; Kamieńska E; Urasiński T; Peregud-Pogorzelski J
Acta Haematol Pol; 1995; 26(1):99-101. PubMed ID: 7747569
[TBL] [Abstract][Full Text] [Related]
15. [L-asparaginase-induced hyperlipidemia in a case of acute lymphoblastic leukemia].
Konya H; Tamura S; Miyazaki E; Inoue N; Okamoto T; Takemoto Y; Kohsaki M; Kanemaru A; Kakishita E
Rinsho Ketsueki; 1991 Mar; 32(3):250-4. PubMed ID: 2041167
[TBL] [Abstract][Full Text] [Related]
16. A new onset drug induced diabetes mellitus presenting with diabetic ketoacidosis in a child undergoing treatment for B cell acute lymphoblastic leukemia. A case report and review of literature.
Sharma P; Vyas V; Didel S; Singh K
J Pediatr Endocrinol Metab; 2024 Apr; 37(4):367-370. PubMed ID: 38281148
[TBL] [Abstract][Full Text] [Related]
17. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
[TBL] [Abstract][Full Text] [Related]
18. Antithrombin supplementation III in childhood acute lymphoblastic leukemia treated with L-asparaginase.
Matsuzaki A; Suminoe A; Hara T
Pediatr Hematol Oncol; 2002 Dec; 19(8):601-3. PubMed ID: 12487838
[TBL] [Abstract][Full Text] [Related]
19. Hyperglycemia, ketoacidosis and other complications of L-asparaginase in children with acute lymphoblastic leukemia.
Cetin M; Yetgin S; Kara A; Tuncer AM; Günay M; Gümrük F; Gürgey A
J Med; 1994; 25(3-4):219-29. PubMed ID: 7996065
[TBL] [Abstract][Full Text] [Related]
20. L-asparaginase induced intracranial haemorrhage in acute lymphoblastic leukemia.
Lim HL; Teo CP; Wong K; Kueh YK
Singapore Med J; 1998 Feb; 39(2):76-8. PubMed ID: 9652181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]